Target Name: ZNF202
NCBI ID: G7753
Review Report on ZNF202 Target / Biomarker Content of Review Report on ZNF202 Target / Biomarker
ZNF202
Other Name(s): Zinc finger protein 202 (isoform 1) | ZN202_HUMAN | zinc finger protein with KRAB and SCAN domains 10 | ZNF202 variant 1 | Zinc finger protein 202, transcript variant 1 | zinc finger protein 202 | Zinc finger protein 202 | ZKSCAN10 | ZSCAN42 | Zinc finger protein with KRAB and SCAN domains 10

ZNF202: Key Regulator of Gene Expression and Potential Drug Target/biomarker

ZNF202, also known as zinc finger protein 202 (isoform 1), is a protein that is expressed in various tissues throughout the body. It is a key regulator of gene expression and has been implicated in the development and progression of various diseases, including cancer. In recent years, researchers have been interested in exploring the potential drug targets and biomarkers for ZNF202.

The zinc finger gene family is a family of non-coding RNAs that contain a conserved core domain of zinc finger proteins and a variable region of non-coding DNA. ZNF202 is a member of this family and is expressed in various tissues, including muscle, liver, and brain. It is a key regulator of gene expression and has been implicated in the development and progression of various diseases, including cancer.

One of the key features of ZNF202 is its zinc finger domain. This domain is composed of a series of conserved amino acids that are known as zinc fingers. ZNF202 has four zinc fingers, each of which is responsible for binding to a specific DNA sequence. These zinc fingers play a crucial role in regulating gene expression and have been implicated in the development and progression of various diseases.

One of the most promising aspects of ZNF202 is its potential as a drug target. Researchers have been interested in exploring the effects of drugs that target ZNF202 and have developed various compounds that are designed to do so. These drugs have been shown to have a variety of biological effects, including inhibiting the growth of cancer cells and protecting against neurodegenerative diseases.

In addition to its potential as a drug target, ZNF202 has also been shown to be a valuable biomarker for several diseases. For example, researchers have used ZNF202 as a biomarker to diagnose and monitor the progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. They have also used it to predict the outcome of patients with cancer, including the risk of recurrence.

Overall, ZNF202 is a protein that has great potential as a drug target and biomarker. Its zinc finger domain and various biological effects make it an attractive target for researchers and clinicians alike. As more research is conducted on ZNF202, it is likely that we will gain a better understanding of its role in the development and progression of various diseases and the potential it holds as a drug and biomarker.

Protein Name: Zinc Finger Protein 202

Functions: Transcriptional repressor that binds to elements found predominantly in genes that participate in lipid metabolism. Among its targets are structural components of lipoprotein particles (apolipoproteins AIV, CIII, and E), enzymes involved in lipid processing (lipoprotein lipase, lecithin cholesteryl ester transferase), transporters involved in lipid homeostasis (ABCA1, ABCG1), and several genes involved in processes related to energy metabolism and vascular disease

The "ZNF202 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF202 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330